Investment from Green Monday Ventures, Eat Beyond Global, KBW Ventures and Verso Capital will allow TurtleTree labs to expand focus into functional components in milk.
Biotech company TurtleTree Labs has announced the close of an oversubscribed US6.2 million pre-A funding round from new and existing global investors including Green Monday Ventures, Eat Beyond Global, KBW Ventures, and Verso Capital. The funds will be used to accelerate research and production of functional, bioactive proteins, and complex sugars found in human milk.
These components are said to have potential benefits in gut and brain health, which can be applied to both infant and senior nutrition.
The company announced that HRH Prince Khaled bin Alwaleed bin Talal Al Saud, a global investor in the alternative protein sector through KBW Ventures, will join TurtleTree Labs as an advisor. KBW Ventures first invested in TurtleTree Labs seed round announced earlier this June, and has committed additional capital to the latest round. In his role as advisor, Prince Khaled will shape new market growth plans, lend his expertise in the alternative protein and food-tech spheres, and liaise closely with the founding team on other areas of the business.
Max Rye, chief strategist of TurtleTree Labs, said: “The vision of TurtleTree Labs is to create a truly sustainable and cruelty-free food system. We are grateful to have the support of leading investors from every corner of the world.”